JAN 04, 2020 11:44 AM PST

Testing Gene Therapy as a Potential Treatment for CTE

WRITTEN BY: Carmen Leitch

Repeated trauma to the head, like a boxer, football player, or soldier might experience, appears to cause a degenerative disease called chronic traumatic encephalopathy (CTE). Researchers are still learning about the disease, and physical evidence connecting repeated head trauma to a disorder was discovered only recently, in 2002 by Dr. Bennet Omalu.

There is no specific symptom that has been conclusively linked to CTE, which can only be diagnosed by a post-mortem examination of the brain. But, symptoms may include problems thinking or carrying out tasks, depression, apathy, impulsive behavior, short-term memory loss, emotional instability, substance abuse, or suicidal thoughts.

Little is known about how the disease progresses or how to treat it. However, a protein called tau is known to build up in the brains of people with CTE, after they become chemically altered in a way that's called hyperphosphorylation. Tau proteins form in a pattern that's specific to CTE, and has also been detected at abnormally high levels in a study of people that had experienced repeated head trauma. That work suggested that high Tau levels may be a biomarker for the disease.

 New research reported in Human Gene Therapy has investigated whether gene therapy might be an effective therapeutic for CTE. Researchers delivered a viral vector (the typical carrier for gene therapy) directly to the brains of a mouse model of CTE. The scientists found that this approach significantly reduced the levels of a hyperphosphorylated form of Tau protein, called pTau.

"CTE is much more prevalent than was initially realized, and there is currently no therapy available," said Human Gene Therapy's Editor-in-Chief Terence R. Flotte, M.D., Celia and Isaac Haidak Professor of Medical Education and Dean, Provost. "This new work from the Crystal laboratory is potentially ground-breaking as a means to remove the offending Tau phoshoprotein."


Sources: AAAS/Eurekalert! via Mary Ann Liebert, Inc./Genetic Engineering News, Human Gene Therapy

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 02, 2020
Genetics & Genomics
JAN 02, 2020
Mysterious Extrachromosomal DNA is Linked to Childhood Cancer
Scientists are learning more about an unusual kind of DNA that's separate from a cell's genomic DNA....
JAN 08, 2020
Microbiology
JAN 08, 2020
Researchers Discover Many New Viruses That are Carried by Insects
Zoonotic diseases are caused by infectious microorganisms like bacteria or viruses, and are passed between animals, including humans....
FEB 03, 2020
Microbiology
FEB 03, 2020
The Switch Controlling the Stage of a Common Parasite
The parasite Toxoplasma gondii is thought to infect from one-quarter to one-third of the global population....
FEB 05, 2020
Clinical & Molecular DX
FEB 05, 2020
A new CRISPR-based test for coronavirus infections
A surge in infections has caused panic surrounding the coronavirus (2019-nCoV) outbreak to reach a fever pitch. Despite being only moderately infective, 20...
FEB 17, 2020
Microbiology
FEB 17, 2020
Giant Viruses Blur the Line Between Life and Non-Life
Bacteriophages, also known as phages, are more complex than many viruses that we know of, and often carry large genomes....
FEB 17, 2020
Cancer
FEB 17, 2020
Listening in on cancer cells
Research published today in Nature Methods reports a new technique of “listening” to cancer cells. While it may sound odd (no pun intended...
Loading Comments...